Technique shows how abnormal RNA splicing leads to disease

A technique that enables scientists to record gene mutations and patterns of gene activity in individual cells has been extended to cover RNA splicing as well, in a study co-led by researchers at Weill Cornell Medicine.

‘Trashbots’ help Brooklynites clean up, connect

Cornell Tech researchers deployed “trashbots” in Brooklyn for two weeks in July. The goal of the experiment was to see how people interact with, and make sense of, service robots in public spaces. The cleaning was an added bonus.

Fowell awarded NIH grant to study T cell behavior

Deborah Fowell, professor and chair of the Department of Microbiology and Immunology in the College of Veterinary Medicine, has received a five-year, $2.32 million MERIT award from the NIH to study the factors that help guide immune cells.

Gene-editing tool helps target small cancer-linked mutations

A new gene-editing tool created by Weill Cornell Medicine investigators will enable cancer researchers to study the impact of specific genetic changes in preclinical models.

COVID boosters show value for those pregnant or trying to conceive

Pregnant women who had a previous COVID-19 infection and received full vaccination and a booster have the strongest immune protection from the disease – and pass that protection along to their unborn babies, according to a new study.

School-based health clinics benefit rural NYS communities

In a rural part of upstate New York, students with access to school-based health centers received more medical care and missed less school, Cornell researchers found.

Library expands video streaming resources 

From Hollywood blockbusters to independent films, visual resources are just a couple of clicks away for Cornell students, faculty, and staff.

Around Cornell

Using broad race categories in medicine hides true health risks

Many medical studies record a patient’s race using only the broad categories from the U.S. Census, which may conceal racial health disparities, a new Cornell-led study reports.

Potential neuropathic pain treatment shows promise in preclinical tests

A non-opioid designer molecule for treating chronic neuropathic pain has had promising results in a preclinical study conducted by researchers at Weill Cornell Medicine and the Burke Neurological Institute.